R. Brillet

发表

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

J. Pawlotsky, D. Dhumeaux, J. Coste, 2002, Journal of Virology.

The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.

F. Penin, J. Pawlotsky, D. Dhumeaux, 2007, The Journal of infectious diseases.

New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.

J. Pawlotsky, Alessandra Nurisso, A. Boumendjel, 2016, European journal of medicinal chemistry.

Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention

J. Pawlotsky, J. Guichou, E. Hernández, 2014, Nucleic acids research.

Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity

J. Pawlotsky, N. Jouvenet, P. Bruscella, 2018, Antimicrobial Agents and Chemotherapy.

Complex dynamics of hepatitis B virus resistance to adefovir

J. Pawlotsky, P. Nordmann, C. Hézode, 2009, Hepatology.

Fitness‐associated substitutions following failure of direct‐acting antivirals assessed by deep sequencing of full‐length hepatitis C virus genomes

J. Pawlotsky, S. Chevaliez, S. Fourati, 2020, Alimentary pharmacology & therapeutics.

Proviral role of human respiratory epithelial cell‐derived small extracellular vesicles in SARS‐CoV‐2 infection

J. Pawlotsky, V. Firlej, P. Maillé, 2022, Journal of extracellular vesicles.

Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real‐time polymerase chain reaction–based method

J. Pawlotsky, S. Chevaliez, M. Bouvier-Alias, 2007, Hepatology.

Small-molecule inhibitors of cyclophilins block opening of the mitochondrial 1 permeability transition pore and protect mice from hepatic ischemia – reperfusion injury 2 3

Jean-François, J. Pawlotsky, J. Calderaro, 2022 .

Third Early “Booster” Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses

J. Pawlotsky, S. Fourati, A. Ahmed-Belkacem, 2022, Viruses.

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry

J. Pawlotsky, S. Jamain, P. Maillé, 2022, Scientific Reports.

Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

J. Pawlotsky, A. Boumendjel, E. Nicolle, 2011, Journal of medicinal chemistry.

Author manuscript, published in "Gastroenterology 2010;138(3):1112-22" DOI: 10.1053/j.gastro.2009.11.053 SILIBININ AND RELATED COMPOUNDS ARE DIRECT INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

J. Pawlotsky, C. Wychowski, Ralf-Torsten Pohl, 2010 .

B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

J. Pawlotsky, A. Boumendjel, A. Ahmed-Belkacem, 2014, European journal of medicinal chemistry.

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.

J. Pawlotsky, F. Roudot-thoraval, D. Dhumeaux, 2007, Journal of hepatology.

Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection

Jean-Michel Pawlotsky, J. Pawlotsky, S. Chevaliez, 2007, Journal of Virology.

Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia-reperfusion injury.

J. Pawlotsky, J. Calderaro, F. Allemand, 2019, Gastroenterology.

Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities

J. Pawlotsky, D. Douguet, W. Bourguet, 2016, Nature Communications.

Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice

J. Pawlotsky, S. Chevaliez, M. Bouvier-Alias, 2009, PloS one.

744 IN VIVO AND IN VITRO RESISTANCE TO SILIBININ, A COMPONENT OF SILYMARIN AND POTENT INHIBITOR OF HCV REPLICATION

J. Pawlotsky, P. Ferenci, K. Zinober, 2010 .

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)

J. Pawlotsky, P. Bruscella, S. Fourati, 2020, Antimicrobial Agents and Chemotherapy.

MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication

J. Pawlotsky, E. Hernández, S. Fourati, 2020, Antimicrobial Agents and Chemotherapy.

OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

J. Pawlotsky, A. Ahmed-Belkacem, C. Pallier, 2010 .

62 Is ribavirin antiviral effect in humans mediated by mutagenic properties resulting in error catastrophe

J. Pawlotsky, D. Dhumeaux, C. Hézode, 2004 .

[55] COMPLEX DYNAMICS OF HEPATITIS B VIRUS RESISTANCE TO ADEFOVIR DIPIVOXIL

J. Pawlotsky, C. Hézode, C. Rodriguez, 2007 .